Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to investigate the negative symptoms and cognitive function after administration of antipsychotics in healthy volunteer.


Clinical Trial Description

n/a


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01185418
Study type Observational
Source Chonbuk National University Hospital
Contact
Status Completed
Phase N/A
Start date March 2009
Completion date July 2009

See also
  Status Clinical Trial Phase
Completed NCT02922933 - A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects Phase 1
Completed NCT02922946 - Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat Phase 1
Completed NCT01250197 - Formulation Comparison in Normal Volunteers Phase 1
Completed NCT02051517 - Vitreous Chemistry Analysis N/A
Recruiting NCT00182858 - Tissue Procurement for Biomedical Research
Completed NCT02828813 - Neural Mechanisms of Motor and Cognitive Networks
Completed NCT02146391 - Study to Evaluate the Effect of Food Upon the Pharmacokinetics of Androxal Phase 1
Terminated NCT00465842 - Protein Biomarker in Hepatocellular Carcinoma
Recruiting NCT02471352 - Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Terminated NCT01752231 - Optimization of Novel DCE-MRI Imaging Sequences for Cancer Therapy Monitoring N/A
Completed NCT02517307 - Fatty Acid Oxidation Defects and Insulin Sensitivity N/A
Completed NCT01366352 - Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets Phase 1
Not yet recruiting NCT01487486 - Proteomics & Glyco-Proteomic Analysis of Follicular Fluid N/A
Completed NCT03993587 - The Effect of Head and Shoulder Positioning on the Cross-sectional Area of the Subclavian Vein in Obese Adults
Completed NCT02860351 - The Effect of Head Positioning on the Cross-sectional Area of the Subclavian Vein. N/A
Completed NCT02113943 - Double Blind Randomized, Monocentric, Cross-over, Placebo-controlled Study to Evaluate the Effect of Citalopram on Motivation Phase 2